Patents Assigned to Bioiberica, S.A.
-
Patent number: 11077136Abstract: The present invention relates to a composition comprising hyaluronic acid, dermatan sulfate, at least one omega-3 fatty acid, and at least one nucleotide. It also relates to the new composition for use in the treatment or prevention of diseases, ailments, dysfunctions, or alterations of the skin, preferably atopic dermatitis. The composition may be in the form of a pharmaceutical composition, food supplement, functional food, or medical food.Type: GrantFiled: April 12, 2017Date of Patent: August 3, 2021Assignee: BIOIBERICA, S.A.U.Inventors: José Escaich Ferrer, Sergi Segarra López, Javier Córdoba Lucio, Jorge Flores García, Alfonso Velasco Franco
-
Patent number: 10729728Abstract: The present invention refers to a process for preparing an animal brain extract. It also refers to the brain extract obtainable according to said process and to the use thereof as a medicine, in particular for the prevention and/or treatment of neurodegenerative diseases and disorders of the central nervous system. It also refers to compositions comprising this extract and to its use for preparing these compositions.Type: GrantFiled: April 25, 2016Date of Patent: August 4, 2020Assignee: BIOIBERICA, S.A.Inventors: Josep Escaich Ferrer, Daniel Martinez Puig, Pere Dalmau Castañares, Ramon Ruhi Roura, Joaquima Guix Salichs, Josep Ribas Maynou, Artur Alfocea Egüén, Antonio Garcia Pedrosa, Purificación Morales García, Pere Leon Martín, Marta Badias Eroles
-
Publication number: 20190192553Abstract: The present invention relates to a composition comprising hyaluronic acid, dermatan sulfate, at least one omega-3 fatty acid, and at least one nucleotide. It also relates to the new composition for use in the treatment or prevention of diseases, ailments, dysfunctions, or alterations of the skin, preferably atopic dermatitis. The composition may be in the form of a pharmaceutical composition, food supplement, functional food, or medical food.Type: ApplicationFiled: April 12, 2017Publication date: June 27, 2019Applicant: BIOIBERICA, S.A.U.Inventors: José ESCAICH FERRER, Sergi SEGARRA LÓPEZ, Javier CÓRDOBA LUCIO, Jorge FLORES GARCÍA, Alfonso VELASCO FRANCO
-
Publication number: 20180140638Abstract: The present invention refers to a process for preparing an animal brain extract. It also refers to the brain extract obtainable according to said process and to the use thereof as a medicine, in particular for the prevention and/or treatment of neurodegenerative diseases and disorders of the central nervous system. It also refers to compositions comprising this extract and to its use for preparing these compositions.Type: ApplicationFiled: April 25, 2016Publication date: May 24, 2018Applicant: BIOIBERICA, S.A.Inventors: Josep ESCAICH FERRER, Daniel MARTINEZ PUIG, Pere DALMAU CASTAÑARES, Ramon RUHI ROURA, Joaquima GUIX SALICHS, Josep RIBAS MAYNOU, Artur ALFOCEA EGÜÉN, Antonio GARCIA PEDROSA, Purificación MORALES GARCÍA, Pere LEON MARTÍN, Marta BADIAS EROLES
-
Patent number: 9687525Abstract: The present invention relates to a method for preparing a cartilage product comprising a protein hydrolysate with a degree of hydrolysis comprised between 0.5% and 3.0%, at least one glycosaminoglycan and at least one growth factor. The present invention also relates to the cartilage product obtainable through said method. Said cartilage product is useful in the treatment or prevention of wounds, ulcers, burns, psoriasis, osteoarthritis, synovitis, osteoporosis, osteopenia, diseases of the tendons and ligaments, periodontal diseases, signs of skin aging, the harmful effects of ultraviolet radiation exposure or stretch marks.Type: GrantFiled: April 20, 2016Date of Patent: June 27, 2017Assignee: BIOIBERICA, S.A.Inventors: Josep Escaich Ferrer, Pere Dalmau Castanares, Ana Maria Torrent Gibert, Ramon Ruhi Roura, Carlos Raul Alaez Verson
-
Patent number: 9420785Abstract: The present invention is related to the use of compositions comprising an enzymatic hydrolysate of animal cartilage protein, at least one organic acid from an alcoholic fermentation, and water, as attractant for flies of the species Drosophila suzukii. Preferably, the animal cartilage is bovine and/or porcine cartilage and the organic acid from an alcoholic fermentation is wine vinegar, apple cider vinegar, white vinegar or rice vinegar.Type: GrantFiled: June 12, 2015Date of Patent: August 23, 2016Assignee: BIOIBERICA, S.A.Inventors: Josep Escaich Ferrer, Anna Botta Català, Manuel Carrión Rodriguez, Cándido Marín Garrido, Núria Sierras Serra, Rafael Piñol Dastis
-
Publication number: 20160228508Abstract: The present invention relates to a method for preparing a cartilage product comprising a protein hydrolysate with a degree of hydrolysis comprised between 0.5% and 3.0%, at least one glycosaminoglycan and at least one growth factor. The present invention also relates to the cartilage product obtainable through said method. Said cartilage product is useful in the treatment or prevention of wounds, ulcers, burns, psoriasis, osteoarthritis, synovitis, osteoporosis, osteopenia, diseases of the tendons and ligaments, periodontal diseases, signs of skin aging, the harmful effects of ultraviolet radiation exposure or stretch marks.Type: ApplicationFiled: April 20, 2016Publication date: August 11, 2016Applicant: BIOIBERICA, S.A.Inventors: Josep ESCAICH FERRER, Pere DALMAU CASTANARES, Ana Maria TORRENT GIBERT, Ramon RUHI ROURA, Carlos Raul ALAEZ VERSON
-
Patent number: 9347081Abstract: The present invention relates to a method for preparing a cartilage product comprising a protein hydrolysate with a degree of hydrolysis comprised between 0.5% and 3.0%, at least one glycosaminoglycan and at least one growth factor. The present invention also relates to the cartilage product obtainable through said method. Said cartilage product is useful in the treatment or prevention of wounds, ulcers, burns, psoriasis, osteoarthritis, synovitis, osteoporosis, osteopenia, diseases of the tendons and ligaments, periodontal diseases, signs of skin aging, the harmful effects of ultraviolet radiation exposure or stretch marks.Type: GrantFiled: April 16, 2012Date of Patent: May 24, 2016Assignee: BIOIBERICA, S.A.Inventors: Josep Escaich Ferrer, Pere Dalmau Castanares, Ana Maria Torrent Gibert, Ramon Ruhi Roura, Carlos Raul Alaez Verson
-
Publication number: 20160032386Abstract: A method for predicting the severity or progression of OA in a human subject, comprising: determining the identity of at least one allele at each of at least 4 positions of single nucleotide polymorphism (SNPs) selected from the group consisting of: rs2206593, rs10465850, rs780094, rs1374281, rs1143634, rs2073508, rs2243250, rs4720262, rs917760, rs7838918, rs12009, rs730720, rs874692, rs893953, rs1799750, rs10845493, rs11054704, rs7986347, rs1802536, rs10519263, rs7342880, rs16947882 and rs10413815, and one or more SNPs in linkage disequilibrium at a level of at least R2?0.8 therewith, as well as products, in particular systems and kits for use in such a method.Type: ApplicationFiled: January 30, 2014Publication date: February 4, 2016Applicants: BIOIBERICA, S.A., PROGENIKA BIOPHARMA S.A.Inventors: Josep Escaich, Josep Vergés, Ruth Alonso, Eulàlia Montell, Helena Martínez, Marta Herrero, Francisco Blanco, Antonio Martínez, Diego Tejedor, Marta Artieda, Nerea Bartolomé
-
Publication number: 20150366194Abstract: The present invention is related to the use of compositions comprising an enzymatic hydrolysate of animal cartilage protein, at least one organic acid from an alcoholic fermentation, and water, as attractant for flies of the species Drosophila suzukii. Preferably, the animal cartilage is bovine and/or porcine cartilage and the organic acid from an alcoholic fermentation is wine vinegar, apple cider vinegar, white vinegar or rice vinegar.Type: ApplicationFiled: June 12, 2015Publication date: December 24, 2015Applicant: BIOIBERICA, S.A.Inventors: Josep ESCAICH FERRER, Anna BOTTA CATALÀ, Manuel CARRIÓN RODRIGUEZ, Cándido MARÍN GARRIDO, Núria SIERRAS SERRA, Rafael PIÑOL DASTIS
-
Patent number: 9161979Abstract: The present invention relates to compositions comprising nucleobases and/or sources of nucleobases and polysaccharides from extracts of fungi, yeasts or bacteria. Preferably, the compositions include Nucleoforce® or Nucleoforce® Dogs and AHCC®. Said compositions are useful in the treatment and prevention of immunosuppression, of the toxicity derived from chemotherapy or radiotherapy treatment, of diseases of the immune system, of cancer or an infection; and are also useful to stimulate the immune function in a mammal, including a human.Type: GrantFiled: September 8, 2009Date of Patent: October 20, 2015Assignee: Bioiberica, S.A.Inventors: Josep Escaich Ferrer, Daniel Martinez Puig, Carles Chetrit Russi, Elisabet Borda Casas, Ken-ichi Kosuna
-
Publication number: 20150182597Abstract: The present invention relates to a composition comprising hyaluronic acid and dermatan sulphate for use in the treatment or prevention of overweight, obesity, insulin resistance, type 2 diabetes, fatty liver or dyslipidemia or for use in reducing food intake, inducing the feeling of satiety, reducing appetite, reducing body weight, preventing weight gain, reducing body fat, reducing fat formation, reducing blood cholesterol, maintaining normal blood cholesterol levels, reducing blood triglycerides, maintaining normal blood triglyceride levels or increasing insulin sensitivity. The composition can further contain collagen hydrolysate. The composition can be in the form of a pharmaceutical composition, a food, a functional food, a medical food or a food supplement.Type: ApplicationFiled: July 22, 2013Publication date: July 2, 2015Applicant: BIOIBERICA, S.A.Inventors: Josep Escaich Ferrer, Ma Luisa Bonet Pina, Daniel Martinez Puig, Nuria Granados Borbolla, Barbara Reynes Miralles, Carles Chetrit Russi, Andreu Palou Oliver
-
Patent number: 8785416Abstract: The present invention relates to the use of a series of sulphated disaccharides for the preparation of a medicament for the treatment or prevention of a neurodegenerative and/or neurovascular disease, of a traumatic brain injury or of a traumatic spinal cord injury. The present invention also relates to the use of said sulphated disaccharides for the preparation of a neuroprotective medicament or of an antioxidant medicament. The neurodegenerative and/or neurovascular diseases are preferably: Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis and stroke.Type: GrantFiled: December 22, 2010Date of Patent: July 22, 2014Assignees: Bioiberica, S.A., Universidad Autonoma de MadridInventors: Josep Verges Milano, Antonio Garcia Garcia, Ramon Ruhi Roura, Eulalia Montell Bonaventura, Manuela Garcia Lopez, Carlos Raul Alaez Verson, Josep Escaich Ferrer, Javier Egea Maiquez, Pilar Negredo Madrigal, Silvia Lorrio Gonzalez
-
Publication number: 20140113861Abstract: The present invention relates to a method for preparing a cartilage product comprising a protein hydrolysate with a degree of hydrolysis comprised between 0.5% and 3.0%, at least one glycosaminoglycan and at least one growth factor. The present invention also relates to the cartilage product obtainable through said method. Said cartilage product is useful in the treatment or prevention of wounds, ulcers, burns, psoriasis, osteoarthritis, synovitis, osteoporosis, osteopenia, diseases of the tendons and ligaments, periodontal diseases, signs of skin aging, the harmful effects of ultraviolet radiation exposure or stretch marks.Type: ApplicationFiled: April 16, 2012Publication date: April 24, 2014Applicant: BIOIBERICA, S.A.Inventors: Josep Escaich Ferrer, Pere Dalmau Castanares, Ana Maria Torrent Gibert, Ramon Ruhi Roura, Carlos Raul Alaez Verson
-
Publication number: 20130263294Abstract: A method for predicting risk of joint dysplasia, osteoarthritis and/or a condition that is secondary to joint dysplasia in a mammalian subject of the order Carnivora, the method comprising: (a) determining the genotype of said subject in respect of one or more genetic polymorphisms and/or alterations, such as polymorphisms in the CHST3 gene; and (b) providing a prediction of said risk based on said genotype. Products for use in such a method and related methods of determining propensity of a subject to respond to therapy and of selective breeding, are also disclosed.Type: ApplicationFiled: September 19, 2011Publication date: October 3, 2013Applicants: BIOIBERICA, S.A., PROGENIKA BIOPHARMA, S.A.Inventors: Antonio Martinez, Laureano Simon, Diego Tejedor, Marta Artieda, Nerea Bartolome, Jose Escaich, Alfonso Velasco, Miriam Selles, Carlos Chetrit, Daniel Martinez, Armand Sanchez, Olga Francino, Elisenda Sanchez
-
Patent number: 8445462Abstract: The present invention relates to compositions comprising chondroitin sulphate and mannosamine or a derivative thereof. The mannosamine derivative is preferably N-acetylmannosamine. The compositions may comprise glucosamine. Said compositions are useful in the treatment or prevention of degenerative joint diseases, preferably of osteoarthritis, in the treatment or prevention of tendon or ligament diseases, disorders or injuries and of immune system diseases, preferably of rheumatoid arthritis.Type: GrantFiled: December 17, 2008Date of Patent: May 21, 2013Assignee: Bioiberica, S.A.Inventors: Josep Escaich Ferrer, Ana Maria Torrent Gibert, Ramon Ruhi Roura, Pere Dalmau Castanares
-
Patent number: 8394781Abstract: Disaccharides for the treatment of tendons, ligaments and bones. The present invention relates to the use of a series of disaccharides, as well as of compositions containing them, for the preparation of a medicament for the treatment or prevention of a tendon, ligament or bone disease, disorder or injury. The present invention also relates to the new compositions comprising a disaccharide in combination with inulin polysulphate, a glycosaminoglycan, a growth factor or cells. The glycosaminoglycan is preferably chondroitin sulphate or hyaluronic acid and the growth factor is IFG-1.Type: GrantFiled: May 15, 2008Date of Patent: March 12, 2013Assignee: Bioiberica, S.A.Inventors: Josep Escaich Ferrer, Ana Maria Torrent Gibert, Ramon Ruhi Roura, Carlos Raul Alaez Verson
-
Publication number: 20120309707Abstract: The present invention relates to the use of a series of sulphated disaccharides for the preparation of a medicament for the treatment or prevention of a neurodegenerative and/or neurovascular disease, of a traumatic brain injury or of a traumatic spinal cord injury. The present invention also relates to the use of said sulphated disaccharides for the preparation of a neuroprotective medicament or of an antioxidant medicament. The neurodegenerative and/or neurovascular diseases are preferably: Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis and stroke.Type: ApplicationFiled: December 22, 2010Publication date: December 6, 2012Applicants: UNIVERSIDAD AUTONOMA DE MADRID, BIOIBERICA, S.A.Inventors: Josep Verges Milano, Antonio Garcia Garcia, Ramon Ruhi Roura, Eulalia Montell Bonaventura, Manuela Garcia Lopez, Carlos Raul Alaez Verson, Josep Escaich Ferrer, Javier Egea Maiquez, Pilar Negredo Madrigal, Silvia Lorrio Gonzalez
-
Patent number: 8296073Abstract: A method for prognosing osteoporosis phenotypes or estimating osteoporosis quantitative traits comprising determining outcomes for selected SNP variables and clinical variables. Products and methods for genotyping multiple osteoporosis associated genetic variations.Type: GrantFiled: July 12, 2007Date of Patent: October 23, 2012Assignees: Progenika Biopharma, S.A., Bioiberica, S.A.Inventors: Ainara Cadaval, Diego Tejedor Hernández, Antonio Martínez Martínez, Laureano Simón Buela
-
Publication number: 20110213020Abstract: The present invention relates to compositions comprising nucleobases and/or sources of nucleobases and polysaccharides from extracts of fungi, yeasts or bacteria. Preferably, the compositions include Nucleoforce® or Nucleoforce® Dogs and AHCC®. Said compositions are useful in the treatment and prevention of immunosuppression, of the toxicity derived from chemotherapy or radiotherapy treatment, of diseases of the immune system, of cancer or an infection; and are also useful to stimulate the immune function in a mammal, including a human.Type: ApplicationFiled: September 8, 2009Publication date: September 1, 2011Applicant: BIOIBERICA, S.A.Inventors: Josep Escaich Ferrer, Daniel Martinez Puig, Carles Chetrit Russi, Elisabet Borda Casas, Ken-ichi Kosuna